Caffeine activates tumor suppressor PTEN in sarcoma cells

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 465-472

  Miwa, Shinji ^a   Sugimoto, Naotoshi ^a   Shirai, Toshiharu ^a   Hayashi, Katsuhiro ^a   Nishida, Hideji ^a   Ohnari, Issei ^a   Takeuchi, Akihiko ^a   Yachie, Akihiro ^a   Tsuchiya, Hiroyuki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Akt; Caffeine; cAMP sarcoma; PTEN

Indexed keywords

CAFFEINE; CISPLATIN; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SARCOMA;

1-METHYL-3-ISOBUTYLXANTHINE; ANTINEOPLASTIC AGENTS; CAFFEINE; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; FORSKOLIN; HUMANS; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; PHOSPHODIESTERASE INHIBITORS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SARCOMA;

EID: 79959961628     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1051     Document Type: Article

References (33)

1. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT: Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59: 4375-4382, 1999. (Pubitemid 29418757)
2. Zhou BB, Chaturvedi P, Spring K, Scott SP, Johansen RA, Mishra R, Mattern MR, Winkler JD and Khanna KK: Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 275: 10342-10348, 2000. (Pubitemid 30202093)
3. He Z, Ma WY, Hashimoto T, Bode AM, Yang CS and Dong Z: Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 63: 4396-4401, 2003.
4. Nishikawa A, Furukawa F, Imazawa T, Ikezaki S, Hasegawa T and Takahashi M: Effects of caffeine on glandular stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N-nitroso-guanidine and sodium chloride. Food Chem Toxicol 33: 21-26, 1995.
5. Valenzuela MT, Mateous S, Ruiz de Almodovar JM and McMillan TJ: Variation in sensitizing effect of caffeine in human tumour cell lines after gamma-irradiation. Radiother Oncol 54: 261-271, 2000. (Pubitemid 30157837)
6. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A and Picci P: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. 15-year experience in 789 patients treated at a single institution. Cancer 106: 1154-1161, 2006.
7. Harris MB, Gieser P, Goorin AM, Ayala A, Shochat SJ, Ferguson WS, Holbrook T and Link MP: Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol 16: 3641-3648, 1998. (Pubitemid 28506779)
8. Souhami RL, Craft AW, van der Eijken JW, Nooij M, Spooner D, Bramwell VH, Wierzbicki R, Malcolm AJ, Kirkpatrick A, Uscinska BM, van Glabbeke M and Machin D: Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350: 911-917, 1997. (Pubitemid 27420527)
9. Tsuchiya H, Tomita K, Mori Y and Asada N: Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 358: 27-35, 1999. (Pubitemid 29066071)
10. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S and Yamamoto N: Caffeine-assisted chemotherapy and minimized tumor excision for non metastatic osteosarcoma. Anticancer Res 18: 657-666, 1998. (Pubitemid 28174888)
11. Hayashi M, Tsuchiya H, Yamamoto N, Karita M, Shirai T, Nishida H, Takeuchi A and Tomita K: Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue. Anticancer Res 25: 2399-2405, 2005. (Pubitemid 41044722)
12. Kimura H, Tsuchiya H, Shirai T, Nishida H, Hayashi K, Takeuchi A, Ohnari I and Tomita K: Caffeine-potentiated chemotherapy for metastatic osteosarcoma. J Orthop Sci 14: 556-565, 2009.
13. Takeuchi A, Tsuchiya H, Yamamoto N, Hayashi K, Yamauchi K, Kawahara M, Miyamoto K and Tomita K: Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome. Anticancer Res 27: 3489-3495, 2007. (Pubitemid 47607491)
14. Miwa S, Kitamura S, Shirai T, Hayashi K, Nishida H, Takeuchi A, Nojima T and Tsuchiya H: Desmoplastic small round cell tumour successfully treated with caffeine-assisted chemotherapy: a case report and review of the literature. Anticancer Res 30: 3769-3774, 2010.
15. Kanamori Y, Kigawa J, Itamochi KH, Shimada M, Takahashi M, Kamazawa S, Sato S, Akeshima R and Terakawa N: Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 7: 892-895, 2001. (Pubitemid 32708726)
16. Steck PA, Pershouse MA, Jasser SA, Yung A, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Travtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997. (Pubitemid 27147102)
17. Whang YE, Wu X, Suzuki H, Tran C, Vessella RL, Said JW, Isaacs WB and Sawyers CL: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246-5250, 1998. (Pubitemid 28208583)
18. Stambolic V, Suzuki A, De la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
19. Vazquez F, Ramaswamy S, Nakamura N and Sellers W: Phosphorylation of the PTEN tail regulated protein stability and function. Mol Cell Biol 20: 5010-5018, 2000. (Pubitemid 30431555)
20. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689, 1997. (Pubitemid 27464966)
21. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H: PTEN modulates cell cycle progression and cell survival by regulating phophatidylinositol 3,4,5-triphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96: 6199-6204, 1999. (Pubitemid 29256643)
22. Lu PZ, Lai CY and Chan WH: Caffeine induces cell death via activation of apoptotic signal and inactivation of survival signal in human osteoblast. Int J Mol Sci 9: 698-718, 2008.
23. Nagasawa S, Takuwa N, Sugimoto N, Mabuchi H and Takuwa Y Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP. Biochem J 385: 737-744, 2005. (Pubitemid 40208834)
24. Sugimoto N, Takuwa N, Yoshioka K and Takuwa Y: Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells. Exp Cell Res 312: 1899-1908, 2006.
25. Loza MJ, Foster S, Peters SP and Penn RB: Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 107: 2052-2060, 2006. (Pubitemid 43289390)
26. Canetti C, Serezani CH, Atrasz RG, White ES, Aronoff DM and Peters-Golden M: Activation of phosphatase and tensin homolog on chromosome 10 mediates the inhibition of FcγR phagocytosis by prostaglandin E2 in alveolar Macrophages. J Immunol 179: 8350-8356, 2007.
27. Nomura M, Ichimatsu D, Moritani S, Koyama I, Dong Z, Yokogawa K and Miyamoto K: Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine. Mol Carcinog 44: 67-76, 2005. (Pubitemid 41216409)
28. Lou YR, Lu YP, Xie JG, Huang MT and Conney AH: Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light. Nutr Cancer 33: 146-153, 1999.
29. Shinomiya N, Takemura T, Iwamoto K and Rokutanda M: Caffeine induces S-phase apoptosis in cis-diamminedichloroplatinum-treated cells, whereas cis-diamminedichloroplatinum induces a block in G2-M. Cytometry 27: 365-373, 1997. (Pubitemid 27158398)
30. Efferth T, Fabry U, Glatte P and Osieka R: Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 121: 648-656, 1995.
31. Hagan MP, Hopcia KL, Sylvester FC and Held KD: Caffeine-induced apoptosis reveals a persistent lesion after treatment with bromodeoxyuridine and ultraviolet-B light. Radiat Res 147: 674-679, 1997. (Pubitemid 27247179)
32. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X and Wu H: PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: 117-130, 2003.
33. Mayo LD and Donner DB: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: 11598-11603, 2001. (Pubitemid 32928774)